BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 21606715)

  • 21. Tumor-induced osteomalacia combined with increased bone resorption postoperatively: A case report.
    Shi L; Tang M; Duan S; Deng F; Zhang Y; Yang J; Hu J
    Medicine (Baltimore); 2023 Jul; 102(27):e34217. PubMed ID: 37417620
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identifying the culprit lesion in tumor induced hypophosphatemia, the solution of a clinical enigma.
    Slot-Steenks MM; Hamdy NA; van de Sande MA; Vriens D; Cleven AH; Appelman-Dijkstra NM
    Endocrine; 2016 Dec; 54(3):642-647. PubMed ID: 27709474
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tumour-induced osteomalacia: a literature review and a case report.
    Dadoniene J; Miglinas M; Miltiniene D; Vajauskas D; Seinin D; Butenas P; Kacergius T
    World J Surg Oncol; 2016 Jan; 14(1):4. PubMed ID: 26744291
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oncogenic osteomalacia should be considered in hypophosphatemia, bone pain and pathological fractures.
    Kaniuka-Jakubowska S; Biernat W; Lewczuk A; Świątkowska-Stodulska R; Sworczak K
    Endokrynol Pol; 2012; 63(3):234-8. PubMed ID: 22744630
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Improving diagnosis of tumor-induced osteomalacia with Gallium-68 DOTATATE PET/CT.
    Clifton-Bligh RJ; Hofman MS; Duncan E; Sim IeW; Darnell D; Clarkson A; Wong T; Walsh JP; Gill AJ; Ebeling PR; Hicks RJ
    J Clin Endocrinol Metab; 2013 Feb; 98(2):687-94. PubMed ID: 23295468
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A Patient of Tumour Induced Osteomalacia Undiagnosed for 11 years.
    Gokhale N; Gokhale Y; Mahajan P
    J Assoc Physicians India; 2018 Apr; 66(4):81-4. PubMed ID: 30347965
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diffuse pain, hypophosphatemia, and a subcutaneous nodule.
    Dewitt CA; Collins MT; Cowen EW
    J Am Acad Dermatol; 2007 Sep; 57(3):509-12. PubMed ID: 17707153
    [No Abstract]   [Full Text] [Related]  

  • 28. Tumour-induced Osteomalacia Secondary to Intracranial Tumours - Report of 2 Cases.
    Gunawat PV; Shaikh ST; Deopujari CE
    J Assoc Physicians India; 2019 Apr; 67(4):85-86. PubMed ID: 31299850
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tumor(s) induced osteomalacia--a curious case of double trouble.
    Sahoo J; Balachandran K; Kamalanathan S; Das AK; Patro DK; Halanaik D; Badhe B
    J Clin Endocrinol Metab; 2014 Feb; 99(2):395-8. PubMed ID: 24297794
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tumor-induced osteomalacia.
    Jan de Beur SM
    JAMA; 2005 Sep; 294(10):1260-7. PubMed ID: 16160135
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Phosphaturic mesenchymal tumor of the tibia with oncogenic osteomalacia in a teenager.
    Farmakis SG; Siegel MJ
    Pediatr Radiol; 2015 Aug; 45(9):1423-6. PubMed ID: 25721582
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A literature review to understand the burden of disease in people living with tumour-induced osteomalacia.
    Minisola S; Barlassina A; Vincent SA; Wood S; Williams A
    Osteoporos Int; 2022 Sep; 33(9):1845-1857. PubMed ID: 35643939
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tumour-induced osteomalacia: a rare cause of chronic pain and weakness.
    Nasr JT; Tohme J; Collins MT; Drake MT; Hartley IR; Sfeir J; Dockery K; Taskin M
    Pract Neurol; 2022 Dec; 22(6):528-531. PubMed ID: 35896375
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Coexistence of tumor-induced osteomalacia and primary hyperparathyroidism.
    Markou A; Tsiama V; Tournis S; Papanastasiou L; Tsiavos V; Dassou A; Vlachou V; Papaliodi E; Asimaki N; Zografos G; Piaditis G
    Endocr Pract; 2011; 17(6):e144-8. PubMed ID: 21940278
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tumor-induced osteomalacia associated with a maxillofacial tumor producing fibroblast growth factor 23: report of a case and review of the literature.
    Mori Y; Ogasawara T; Motoi T; Shimizu Y; Chikazu D; Tamura K; Fukumoto S; Takato T
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Mar; 109(3):e57-63. PubMed ID: 20219587
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tumor-induced hypophosphatemic osteomalacia caused by a mesenchymal tumor of the mandible managed by a segmental mandibulectomy and microvascular reconstruction with a free fibula flap.
    Acharya RP; Won AM; Moon BS; Flint JH; Roubaud MS; Williams MD; Hessel AC; Murphy WA; Chambers MS; Gagel RF
    Head Neck; 2019 Jun; 41(6):E93-E98. PubMed ID: 30859653
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Osteomalacia induced by a phosphaturic mesenchymal tumor secreting fibroblast growth factor 23.
    Nagae K; Uchi H; Ito T; Moroi Y; Oda Y; Furue M
    Eur J Dermatol; 2015 Apr; 25(2):199-200. PubMed ID: 25788099
    [No Abstract]   [Full Text] [Related]  

  • 38. [Tumor-induced osteomalacia caused by a late-revealing phosphaturic mesenchymal tumor].
    Chazal T; Khanine V; Lidove O; Godot S; Ziza JM
    Rev Med Interne; 2017 Jun; 38(6):412-415. PubMed ID: 27659744
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tumor-induced osteomalacia: lessons learned.
    Lewiecki EM; Urig EJ; Williams RC
    Arthritis Rheum; 2008 Mar; 58(3):773-7. PubMed ID: 18311810
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oncogenic osteomalacia from nasal cavity giant cell tumor.
    Battoo AJ; Salih S; Unnikrishnan AG; Jojo A; Bahadur S; Iyer S; Kuriakose MA
    Head Neck; 2012 Mar; 34(3):454-7. PubMed ID: 22311466
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.